| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $609.8M | +18.2% |
| Cost of Revenue | $387.2M | +22.1% |
| Gross Profit | $222.6M | +12.0% |
| R&D Expense | $399K | +0.3% |
| SG&A Expense | $140.1M | +12.1% |
| Operating Income | $82.5M | +11.8% |
| Pre-tax Income | $93.0M | +31.3% |
| Income Tax | $21.7M | +45.9% |
| Net Income | $71.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $196.9M | +19.6% |
| Accounts Receivable | $81.5M | +28.5% |
| Inventory | $111.5M | +33.3% |
| Current Assets | $421.4M | +23.5% |
| Total Assets | $461.2M | +27.3% |
| Current Liabilities | $116.4M | +12.7% |
| Total Liabilities | $129.6M | +25.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.2M | +10.0% |
| Capital Expenditures | $8.1M | +736.7% |
| Investing Cash Flow | -$8.3M | -747.3% |
| Financing Cash Flow | -$7.5M | +9.2% |
| Free Cash Flow | $39.0M | -6.9% |
| +27.5% |
| EPS (Basic) | $1.25 | +26.3% |
| EPS (Diluted) | $1.19 | +26.6% |
| Stockholders' Equity |
| $331.5M |
| +28.1% |